SWOG Network Group Operations Center of the NCTN

NCTN SWOG 网络集团运营中心

• 批准号: 10159081
• 负责人: CHARLES D. BLANKE
• 金额: $ 169.32万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10159081
• 关键词: Advocate; Affect; American; Clinical Trials; Conceptions; Data Reporting; Development; Ensure; General Population; Goals; Investments; Leadership; Life; Malignant Neoplasms; Mission; Patients; Population; Recording of previous events; Research; Research Personnel; Safety; Southwest Oncology Group; Training; cost; cost effective; member; operation; programs; tool; treatment trial

SWOG's overarching goal is to conduct high-impact cancer trials with results meaningful to our investigators and patients. In a recent analysis, SWOG investigators examined how our treatment trials have benefited patients with cancer in the general population over the course of its 60-year history (Unger, JAMA Oncol 2017). Three and one-third million life-years were gained in the population of US patients with cancer through 2015, at an investment dollar cost on the part of the NCI of $125 per life-year gained. This clearly illustrates how the NCI's investment in its cancer cooperative group research program has provided exceptional value and benefit to the American public. We will continue to develop and conduct trials aimed at making a significant, cost-effective difference for those affected by cancer.

SWOG 的首要目标是进行高影响力的癌症试验，其结果对我们的研究人员和 患者。在最近的一项分析中，SWOG 研究人员检查了我们的治疗试验如何使患者受益 在其 60 年的历史中，普通人群中癌症的发病率很高（Unger，JAMA Oncol 2017）。三 到 2015 年，美国癌症患者的生命年增加了三分之一 NCI 每增加一个生命年的投资成本为 125 美元。这清楚地说明了 NCI 如何 对其癌症合作小组研究计划的投资为该组织提供了非凡的价值和利益 美国公众。我们将继续开发和进行试验，旨在取得显着的、具有成本效益的结果 癌症患者的差异。